Experiential Learning with Ketamine: A Mixed-Methods Exploratory Study on Prescription and Perception.
Annette M IlgChristine P BeltranJenny A ShihTuyen T YankamaMargaret M HayesAri L MoskowitzPublished in: Therapeutics and clinical risk management (2024)
Despite a substantial increase in ketamine prescription during COVID-19, intensivists continued to feel discomfort with utilization. Factors contributing to this discomfort include a lack of evidence, a lack of experience, and a desire for more education and protocols. Increase in experience with ketamine alone was not sufficient to minimize provider discomfort. These findings should inform future curricula and call for process improvement to optimize continuing education.